Dependency Care

Why Provide Opioid Substitution Programs?

A patient well managed on opioid substitution treatment will be free of withdrawal symptoms and more able to function as a normal member of the community. Opioid Substitution Treatment dramatically reduces crime and deaths from overdose as well as reducing risk of HIV infection.

What Drugs are Available?

Methadone has a long proven record for successfully treating heroin dependence. Since October 2000 Buprenorphine has been available as an alternative treatment with a similar success rate. In April 2006 Suboxone (bupenorphrin/naloxone) became available as another treatment option.

Why Dose from Pharmacies?

A well managed pharmacotherapy program in Community Pharmacy should be professionally rewarding. A recent survey of patients in Public Clinics has revealed that over 80% of patients would prefer to receive their treatment in Community Pharmacies. The utilisation of Patient Methadone Agreements and treatment plans with the doctor and pharmacist defines the objectives and expectations for each patient in treatment.

What Support is Available?

Under the NSW Government Pharmacy Incentive Scheme pharmacists and prescribing doctors will be consulting with their local Area Health Service to produce the best health outcome for the patient and their families. The coordinated care approach will chart the progress of the patient as well as offer family support as required. Currently the State Wide Advisory Team (SWAT) is evaluating and coordinating activities with Area Health Services, Divisions of General Practice and Community Pharmacy.

Who Can I CONTACT at the Guild

Contact Person at the Pharmacy Guild is Paul Jones, Project Manager, Pharmacotherapy Incentive Scheme.
Phone: (02) 9467 7100  |  Email:

Further Information

Was this page useful to you?

Do you want us to contact you?
To contact your local branch representative directly, please see the details on our contact page.
You can also help us improve the website by completing a short survey.
Page last updated 23 February 2017